and its subsidiaries’ total revenue earned for Q.3/2019 totaled Baht 370.14 million, increased from the Q.3/2018 totaled Baht 313.56 million, which was increased of Baht 56.58 million or 18.05 percent

204.0 million, decreased by THB 36.9 million or 15.3% from the prior period and also decreased by THB 38.2 million or 15.8% from the same period of prior year. It mainly decreased from revenue from

percent decline, compared to the previous year. The additional details will be described as follows: 1. Revenue from contract work In 2018, the Company and its subsidiaries had revenue from contract work

89% compared to prior year which were net loss of Baht 169 million. The operating results changed over 20%, main variances due to the following reasons: 1. Revenue from sales and services increase from

Company and its subsidiary for the fiscal year ended on 31 December 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical

Q4 2017 reached 1,841.58MB, an increase of 31% from 1,408.07MB in Q4 2016. This mainly resulted from a 31% increase in USD zinc price despite a 7% appreciation of Thai Baht against USD. The USD zinc

. Revenues (Thousands Baht) Year Change 4th Quarter Change Amount % Amount % Revenue from sales 1,566,147 1,477,687 88,461 5.99% 437,506 371,485 66,021 17.77% Other income 19,457 14,472 4,985 34.45% 6,968

of the Company For the Year ended December 31, 2018 2017 (Restated) Changes % Revenues : Revenues from sales and services 987.27 930.88 56.39 6.06 Gain on purchase price lower than fair value 130.98

: Million Baht Operating results of the Company For the Year ended December 31, 2018 2017 (Restated) Changes % Revenues : Revenues from sales and services 987.27 930.88 56.39 6.06 Gain on purchase price lower

increased 4,614,126 baht or 98.64% more than 20%. The main reasons were as follows: 1. Service income decreased 1,528,845 baht compared to the same period of the last year mainly from the decrease of income